Nippon Gene is a biotechnology company that manufactures and supplies research reagents across Japan, according to a release. The company's portfolio of reagents for research includes enzymes, buffers and reagents for loop-mediated isothermal amplification (LAMP) and polymerase chain reaction (PCR) kits. Nippon Gene also provides plant disease diagnostic kits, allergen detection kits, and antibiotics detection kits in addition to pregnancy and ovulation tests.

The license allows Nippon Gene to develop, manufacture, and sell research reagents using CRISPR-Cas9 technology.

Financial details of the agreement were not disclosed.

Genoway licenses CRISPR/Cas9 tech from ERS Genomics
French company Genoway has entered a nonexclusive license agreement with ERS Genomics that grants Genoway past and future access to ERS Genomics' CRISPR/Cas9...

ERS Genomics, GenScript sign CRISPR/Cas9 license deal
ESR Genomics has agreed to nonexclusively license its CRISPR/Cas9 patent portfolio to GenScript.

ERS Genomics licenses gene editing tech to G+FLAS
ERS Genomics has signed a nonexclusive licensing deal granting G+FLAS Life Sciences access to its CRISPR/Cas9 patent portfolio.

Vivlion licenses CRISPR tech from ERS Genomics
Vivlion has signed a nonexclusive license agreement to access ERS Genomics' CRISPR/Cas9 patent portfolio to enhance Vivlion's gene editing reagents and...